Article

First-time Usage of SGLT2 Inhibitors in Patients with Type 2 Diabetes Who Are Fasting Ramadan: Efficacy and Safety

2024-08-06

Abstract excerpt

<title>Abstract</title> <p><bold>Introduction</bold>: Ramadan fasting claims a necessary role in management of diabetes. Many people with type 2 diabetes insist on fasting during the holy month of Ramadan, which represents a challenge to their physicians to provide balance between preventing hypoglycemia or diabetic ketoacidosis and good control of hyperglycemia with its short- and long-term complications. Sodium...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 5bb45dcd-447a-5400-86e4-2904d8baf50e
DOI: 10.21203/rs.3.rs-4473992/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

First-time Usage of SGLT2 Inhibitors in Patients with Type 2 Diabetes Who Are Fasting Ramadan: Efficacy and SafetyDOI 10.21203/rs.3.rs-4473992/v1Read

Modern Hypoglycemic Agents and Their Perioperative ImplicationsSemantic proximity Read

A Brief Review of Incretin Mimetics Intended for the Management of Diabetes and Associated ComorbiditiesSemantic proximity Read

Recent Trends in Therapeutic Approaches for Diabetes Management: A Comprehensive Update.Semantic proximity Read

Extraglycemic effects of sodium glucose cotransporter 2 inhibitors with a systemic approach, from possibilities to certaintySemantic proximity Read

Vidangadi Lauha’ for Obese Type 2 Diabetes mellitus; Randomised controlled clinical studySemantic proximity Read

Effect of Once Weekly Semaglutide in Patients with Type 2 Diabetes in National Guard Primary Health Care, Jeddah, Saudi Arabia: a retrospective cohort study.Semantic proximity Read

Predisposing factors for the development of diabetic ketoacidosis with lower than anticipated glucose levels in type 2 diabetes patients on SGLT2-inhibitors: a review.Semantic proximity Read

Are sodium-glucose cotransporter-2 inhibitors safe adjunctive drugs during insulin therapy in young children with type 1 diabetes? The first case of type 1 diabetes with SLC5A2 mutation.Semantic proximity Read

Evaluating Diabetes-Specific Meal Replacements for Glycaemic Control in Overweight and Obese T2DM Patients: A Protocol for a Randomized Controlled TrialSemantic proximity Read

A review of nateglinide in the management of patients with type 2 diabetes.Semantic proximity Read

Seven-day Fasting as a multimodal complex interventionfor Adults with Type 1 Diabetes – Feasibility, Benefit and Safety in a Controlled Pilot StudyFeasibility of Fasting for Adults with Type 1 Diabetes Semantic proximity Read

SGLT2 Inhibitors and Potential Applications in Treating Metabolic SyndromeSemantic proximity Read